Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition
Au-Yeung G, Etemadmoghadam D, Drapkin R, Karst A, Rischin D, Mileshkin L, Pearson R, Cullinane C, Aziz D, Lackovic K, Jarman K, Mitchell C, Azar W, Winder F, Bowtell D. Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition. Clin Cancer Res 2017; 23:1862-1874.
Sep 23, 2017
Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition
Sep 23, 2017
Clin Cancer Res 2017; 23:1862-1874
Au-Yeung George, Etemadmoghadam Dariush, Drapkin Ronny, Karst Alison M, Rischin Danny, Mileshkin Linda, Pearson Richard B, Cullinane Carleen, Aziz Diar, Lackovic Kurt, Jarman Kate E, Mitchell Chris, Azar Walid J, Winder Franziska, Bowtell David D L
more
